Literature DB >> 18275982

Primary intrathoracic low-grade fibromyxoid sarcoma.

Joseph D Jakowski1, Paul E Wakely.   

Abstract

Low-grade fibromyxoid sarcoma (LGFMS) is a rare neoplasm commonly affecting young adults and typically arising in the somatic soft tissue of the proximal extremities. Its occurrence within the thoracic cavity is exceedingly rare. We report an LGFMS arising from the epicardial surface of the right side of the heart in a 44-year-old woman. Diagnosis was aided by a strikingly characteristic light microscopic appearance of a bland spindle cell sarcoma containing numerous so-called giant collagen rosettes and supported by immunohistology, evidence of FUS translocation by fluorescence in situ hybridization, and electron microscopy demonstrating a fibroblastic phenotype. Aspiration cytology showed a nonspecific bland spindle cell lesion. Review of the literature uncovered 5 previously reported examples of intrathoracic LGFMS. Low-grade fibromyxoid sarcoma is probably an underrecognized intrathoracic neoplasm and should be considered in the differential diagnosis of spindle cell neoplasms of the mediastinum, pleura, heart, and lungs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275982     DOI: 10.1016/j.humpath.2007.08.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

Review 1.  Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature.

Authors:  Morgan L Cowan; Lester D Thompson; Marino E Leon; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2015-08-15

2.  Successfully resected intrathoracic low-grade fibromyxoid sarcoma.

Authors:  Mitsunori Higuchi; Hiroyuki Suzuki; Yutaka Shio; Sayuri Hoshi; Mitsukazu Gotoh
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

3.  Low-grade fibromyxoid sarcoma of the medial vastus: a case report.

Authors:  Angela Notarnicola; Lorenzo Moretti; Maria Pia Cocca; Antonio Martucci; Umberto Orsini; Biagio Moretti
Journal:  Musculoskelet Surg       Date:  2010-04-08

4.  Case Report: Primary Thoracic Low-Grade Fibromyxoid Sarcoma in a Young Girl Presenting With Mediastinal Mass Syndrome.

Authors:  Yat Chi Chan; Amanda N C Kan; Liz Y P Yuen; Innes Y P Wan; Kevin K F Fung; Yiu-Fai Cheung; Karen K Y Leung; Dennis T L Ku; Anthony P Y Liu
Journal:  Front Pediatr       Date:  2022-06-17       Impact factor: 3.569

Review 5.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

6.  Massive low-grade fibromyxoid sarcoma presenting as acute respiratory distress in a 12-year-old girl.

Authors:  Michael A Steiner; Henry W Giles; William P Daley
Journal:  Pediatr Radiol       Date:  2009-02-10

7.  The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.

Authors:  Barry Rose; George S Tamvakopoulos; Kamaljit Dulay; Robin Pollock; John Skinner; Timothy Briggs; Steven Cannon
Journal:  J Orthop Surg Res       Date:  2011-03-15       Impact factor: 2.359

Review 8.  Mesenchymal tumours of the mediastinum--part I.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

Review 9.  Low-grade fibromyxoid sarcoma incidentally discovered as an asymptomatic mediastinal mass: a case report and review of the literature.

Authors:  Mir Ibrahim Sajid; Sidra Arshad; Jamshid Abdul-Ghafar; Saulat Hasnain Fatimi; Nasir Ud Din
Journal:  J Med Case Rep       Date:  2021-02-02

Review 10.  Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors.

Authors:  Jack Porrino; Khalid Al-Dasuqi; Lina Irshaid; Annie Wang; Kimia Kani; Andrew Haims; Ezekiel Maloney
Journal:  Skeletal Radiol       Date:  2021-06-30       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.